Pathstone Family Office’s Cerence CRNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$207K Buy
10,048
+2,589
+35% +$65.1K ﹤0.01% 1502
2023
Q2
$247K Buy
+7,459
New +$205K ﹤0.01% 1053
2023
Q1
Sell
-30,910
Closed -$444K 1278
2022
Q4
$444K Buy
+30,910
New +$529K ﹤0.01% 1152
2021
Q4
Sell
-2,808
Closed -$270K 913
2021
Q3
$270K Buy
2,808
+9
+0.3% +$983 0.01% 708
2021
Q2
$298K Buy
2,799
+420
+18% +$41.3K 0.01% 649
2021
Q1
$213K Buy
2,379
+2,314
+3,560% +$255K 0.01% 592
2020
Q4
$6K Sell
65
-269
-81% -$20.1K ﹤0.01% 929
2020
Q3
$17K Buy
334
+300
+882% +$14.4K ﹤0.01% 504
2020
Q2
$1K Hold
34
﹤0.01% 667
2020
Q1
$1K Buy
+34
New +$715 ﹤0.01% 712

Other funds holding CRNC

Pathstone Family Office's CRNC Position: Q3 2023 in Review

Pathstone Family Office increased its Cerence (CRNC) stake by 35% in Q3 2023, buying an estimated $65.1K and bringing the position to 10,048 shares worth $207K. The position accounts for ﹤0.01% of the portfolio, ranked #1502.

Pathstone Family Office first reported a position in CRNC in Q1 2020 and has held it in 10 quarters since. The position peaked at $444K in Q4 2022. 216 funds tracked by Wall St. Rank hold CRNC as of Q3 2023.

  • Pathstone Family Office held 10,048 shares of Cerence worth $207K as of Q3 2023.
  • Pathstone Family Office bought 2,589 Cerence shares in Q3 2023, an estimated $65.1K.
  • Cerence made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1502 holding.
  • Pathstone Family Office first reported a position in Cerence in Q1 2020 and has held it in 10 quarters since.
  • Pathstone Family Office's Cerence position peaked at $444K in Q4 2022.
  • 216 funds tracked by Wall St. Rank held Cerence as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.